Small Molecule Therapy

Which specific companies in the Dementia Discovery Fund portfolio are developing antibodies, gene therapies, or small molecules for Alzheimer’s?

manages a portfolio of companies aimed at discovering disease‑modifying therapeutics for dementia and has backed roughly 19 companies, several of which are pursuing ‑focused programs, but the publicly...